Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_assertion description "[Collectively, our data indicate that ERBB2-mediated breast cancer progression requires ?-catenin signaling and can be therapeutically targeted by selective ?-catenin/CBP inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_assertion evidence source_evidence_literature NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_assertion SIO_000772 23720052 NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_assertion wasDerivedFrom befree-20150227 NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_assertion wasGeneratedBy ECO_0000203 NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP921309.RA_GJxcuUa-GLmUd9CefxDsHhX9Vh2GnYbdBbIzJ-0huc130_provenance.